38-5 History/柴

Size: px
Start display at page:

Download "38-5 History/柴"

Transcription

1

2 V o l. 3 8 N o. 5 ( )

3

4 V o l. 3 8 N o. 5 ( )

5

6 V o l. 3 8 N o. 5 ( )

7

8 V o l. 3 8 N o. 5 ( )

9

10 V o l. 3 8 N o. 5 ( )

11

12 Jpn Heart J Acta Med Scand Z Kreislaufforsch Jpn Heart J Herz Jpn Heart J V o l. 3 8 N o. 5 ( )

1 1 4 8 8 9 1 10 10 10 10 10 5 11 13 13 19 20 21 1 25 25 25 26 26 28 28 29 29 1 30 30 30 30 31 31 31 31 31 31 10 32 11 32 1 3 21 9 24 193 2 24 4 26 1 2 4 5 3 4 5 6 1 3 7 1 1 2 3 6 10 7 8 9 10 11 12

More information

2016select追加小冊子_0704出稿0706修正.indd

2016select追加小冊子_0704出稿0706修正.indd -JPN3 -JPN3 -G1 -G1 -G3 -OP -OP -OP -G3 -G3 -G3 -G3 -G3 -L -L -G1 -JPN1 -OP -G3 -OP -JPN2 -G3 -JPN1 -G3 -G3 -L-L -L -L -G3 -L -L -G2 -L -G3 -G1 -G2 -G2 -G3 -L -G1 -G2 -G3 -G1 -G3 -L -L -L -G3 -G3 -L -G1

More information

2

2 FAX-2840 2 http://solutions.brother.co.jp/ https://myportal.brother.co.jp/ Version 0 JPN 2 3 4 5 2 3 4 6 2 3 2 3 2 3 2 3 7 8 2 3 2 3 9 2 3 2 3 2 3 2 3 0 2 3 2 3 2 3 4 2 3 2 2 3 2 5 6 2 3 2 3 2 3 2 3 7

More information

Q-...g.L..465

Q-...g.L..465 20 8 H e a r t F u l l I n f o r m a t i o n No.465 2 Heart Full Information 3 3 27 6 0 22 3 Heart Full Information 29 42 79 50 29 20 30 5 9 5 5 22 96 86 22 4 Heart Full Information 53 24 5 Heart Full

More information

437“ƒ

437“ƒ et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer

More information

untitled

untitled 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Int J Radiat Oncol Biol Phys 49 Cancer 101 Int J Radiat Oncol Biol Phys 60 Chest 124 Int J Radiat Oncol Biol Phys 56 Int J Radiat Oncol Biol Phys 49 Chest 124 Int J

More information

2

2 FAX-2810N 1 2 http://solutions.brother.co.jp/ https://myportal.brother.co.jp/ Version B JPN 2 3 4 5 6 1 2 3 5 6 7 4 12 11 10 9 8 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 7 200 mm 200 mm 200 mm 200 mm 8 3

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション 3Q 3Q 3Q 3Q 7:00 014 7:30) 051 7:00) 20051 2005/ 051 9 20053 PS2&GC 2 2 2Max Heart 2 DVD 26 14,000 BOX BOX 15,000 26 5,000 DVD \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ 20052

More information

10号安場完成稿本文のみ.PDF

10号安場完成稿本文のみ.PDF 10 ( ) 1 http://www.mext.go.jp/a_menu/shotou/houdou/index.htm ( 13 ) 1 2 3 2 (2000) (2000) 3 2 3 1060% ( 02/10/18) 4 80 90 ( ) ( ) ( 12 7 ) 5 (2001/1/26) 2001 5 ~8 2002 4 ( ) ( 1. 4 5 12 5 6 7 2. ( ) 1.

More information

imageRUNNER ADVANCE C2230F/C2220/C2220F はじめにお読みください

imageRUNNER ADVANCE C2230F/C2220/C2220F はじめにお読みください JPN 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 27 1 2 3 4 5 28 1 19 2 3 4 6 5 18 17 16 15 14 13 9 8 7 12 11 10 1 2 3 4 5 6 7 8 9

More information

untitled

untitled Fig.1 t O O N,N p n J J J J J t J J J J J J J J J J J t t J J J J J J J J J p Fig.2 p t Fig.3 Fig.4 synanti p Table1 Table2t Table2 synanti antisyn synanti synanti Fig.5 syn anti anti Fig.6 Table3 Table4

More information

JPN-1

JPN-1 EF70-200mm f/2.8l IS II USM JPN JPN-1 a JPN-2 JPN-3 1. JPN-4 2. 3. JPN-5 4. JPN-6 5. JPN-7 6. JPN-8 7. JPN-9 JPN-10 8. 9. JPN-11 10. JPN-12 11. 12. 13. JPN-13 14. JPN-14 JPN-15 canon.jp/ef 050-555-90001

More information

MP-E 65mm f/2.8 1-5× 使用説明書

MP-E 65mm f/2.8 1-5× 使用説明書 MACRO PHOTO LENS MP-E 65mm f/2.8 1-5 JPN JPN-1 a JPN-2 JPN-3 1. 2. JPN-4 JPN-5 JPN-6 3. JPN-7 JPN-8 4. JPN-9 5. JPN-10 6. 7. JPN-11 8. JPN-12 canon.jp/ef 050-555-90001 JPN-13 CT1-7525-010 CANON INC. 2002

More information

DocHdl2OnPRS1tmpTarget

DocHdl2OnPRS1tmpTarget 2018 2018 P.12 4 P.20 13 P.2 P.3 4 P.12 2018 4 P.12 13 JRA 3 26 5 1 11 13 25 10 12 b 2018 500 1040 40 13 0 500 0 500 1,000 1,000 5 5 2 2 10 20 30 40 100/108 2 500 800 0 500 500 0 500 1,000 300 30010 300,000

More information

日本皮膚科学会雑誌第121巻第11号

日本皮膚科学会雑誌第121巻第11号 β Clin Rheumatol Arthritis Rheum Am J Cardiol J Rheumatol J Rheumatol Arthritis Rheum Arthritis Rheum Arthritis Rheum Rheumatology Oxford Rheumatology Oxford Br J Dermatol Arch Dermatol Ann Rheum Dis

More information

ONLINE_MANUAL

ONLINE_MANUAL JPN ii iii iv v 6 vi vii viii 1 CHAPTER 1-1 1 2 1-2 1 2 3 4 5 1-3 6 7 1-4 2 CHAPTER 2-1 2-2 2-3 1 2 3 4 5 2-4 6 7 8 2-5 9 10 2-6 11 2-7 1 2 2-8 3 (A) 4 5 6 2-9 1 2-10 2 3 2-11 4 5 2-12 1 2 2-13 3 4 5

More information

ONLINE_MANUAL

ONLINE_MANUAL JPN ii iii iv v vi 6 vii viii 1 CHAPTER 1-1 1 2 1-2 1 2 3 1-3 4 5 6 7 1-4 2 CHAPTER 2-1 2-2 2-3 1 2 3 4 5 2-4 6 7 8 2-5 9 10 2-6 11 2-7 1 2 2-8 3 (A) 4 5 6 2-9 1 2-10 2 3 2-11 4 5 2-12 1 2 2-13 3 4 5

More information

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Journal Physiology, American Journal of Physiology, Journal of Physiology, Journal of Autonomic Nervous System, American Journal of Physiology,

More information

2

2 MFC-7340 1 2 http://solutions.brother.co.jp/ https://regist.brother.jp/ Version 0 JPN 2 3 4 STEP1 接 続 設 置 する 5 6 7 5 1 2 3 6 4 8 1 4 2 3 5 9 1 10 11 12 13 1 2 14 1 2 3 4 5 6 15 1 2 3 4 5 16 1 2 3 4 17

More information

59...ec6

59...ec6 No.59 2012 1 SIV SIV SIV HA NA PB1 PB2 PA NP M NS (H3N2) SIV (H1N1) SIV (H1N1) (H3N2) (H1N1) H1N2 H3N2 H1N2 H1N1 SIV (H1N1)2009 2 Proc Jpn Pig Vet Soc No.59 2012 No.59 2012 3 4 Proc Jpn Pig Vet Soc No.59

More information

3) Z. Nambu: in preparation (1971). 4) N. P. Wilkins & J. D. Iles: Comp. Biochem. Physiol., 17, 1141 (1966). 5) V. M. Ingram: Nature, 235, 338 (1972). Bacillus cereus var. mycoides, Bacillus thuringiensis

More information

NPO JR 74 NPO

NPO JR 74 NPO 73 X NPO NPO JR 74 NPO 75 76 NPO it OK OK OK OK NPO OK Sense of Wonder Hand Head Heart 77 sustainability 78 NPO PPK NPO 79 80 NPO NPO NPO Sense of Wonder PR NPO JR 81 82 NPO,, NHK 83 Sense of Wonder NHK

More information

; cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml Mφ 6 7, 8 9

; cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml Mφ 6 7, 8 9 32, 21-25, 2012 CASLE 1 1 80 26 6 5 4 cm 1 2 CEA 3 4 CEA 2 44 22 2 3 1.5 cm 22 1. 1 ; 6 5 4 cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml 0-40 5 Mφ 6 7, 8 9 23 6. ; 9. ; 7. ; 10. ; 8. 7 10 CK3 CK3 24 1,2 3 2 8% 4,5

More information

ライフサイエンス関連 コラーゲン・ゼラチン製品案内 2015.12

ライフサイエンス関連 コラーゲン・ゼラチン製品案内 2015.12 3 mg/ml ph 3 4 8 1 Type I-A Type I-P Type I-A Type I-C Type III Type III Type IV Type IV TEL 072-820-3079 FAX 072-820-3095 4 8 4 Type I-A 20mL 1 F-12 MEM 5mL 1 4mL 5 10F-12MEM DFDME F-12 1 1199 5 DMERPMI-1640

More information

表紙PDF作成用/PDF表紙作成用

表紙PDF作成用/PDF表紙作成用 2010 Vol.52 No.2! ! Jpn J School Health Jpn J School Health Jpn J School Health! Jpn J School Health Aichi University of Education Nagoya University "! Jpn J School Health! Graduate School of Public Health

More information

3 4 6 7 8 9 10 12 14 2 3

3 4 6 7 8 9 10 12 14 2 3 3 4 6 7 8 9 10 12 14 2 3 POINT 4 5 3053 1323 4 7 6 1 1 4 7 Yamada N. et al : Int J Cardiol. 98, 409-411, 2005 6 7 POINT 0 20 40 60 80 100 60 80 Ota M. et al: Heart Vessels. 17, 7-11,2002 40 60 20 50 15

More information

4) H. Takayama et al.: J. Med. Chem., 45, 1949 (2002). 5) H. Takayama et al.: J. Am. Chem. Soc., 112, 8635 (2000). 6) H. Takayama et al.: Tetrahedron Lett., 42, 2995 (2001). 9) M. Kitajima et al: Chem.

More information

レーザビームプリンタ Satera ネットワークガイド/本編

レーザビームプリンタ Satera ネットワークガイド/本編 JPN ii iii iv v 7 vi vii viii 1 CHAPTER 1-1 1-2 1-3 1-4 1-5 1-6 1-7 1-8 2 CHAPTER 2-1 2-2 1 2 3 4 2-3 5 6 2-4 7 8 2-5 9 2-6 10 2-7 ERR LNK 100 NB-C1 2-8 11 12 2-9 2-10 13 2-11 14 15 2-12 16 17 2-13 18

More information

SK-euglobulin streptokinase-euglobulin activity= total plasmin) euglobulinstreptokinase SK) SP-euglobulin (spontaneous-euglobulin activity=free plasmin) free plasmin 3) anti plasmin =SK-euglobulin lysis

More information

11) Kumar, R., et al.: Lancet, 1 : 90, 1973. 12) Baek, S. M., et al.: Ann. Surg., 177: 253, 1973. 13) Beak, S. M., et al.: Ann. Surg., 178 : 605, 1978. 14) Beak, S. M., et al.: Surgery, 77: 632, 1975.

More information

Key words: change serotype, Pseudomonas aeruginosa anti-pseudomonal drug,

Key words: change serotype, Pseudomonas aeruginosa anti-pseudomonal drug, Key words: change serotype, Pseudomonas aeruginosa anti-pseudomonal drug, Table 1 Incidence of changes in serotype of Pseudomonas aeruginosa isolates induced by anti-pseudomonal drugs Number of isolates

More information

. 0.18 0.16 0.16 0.14 0.12 0.1 0.08 0.06 0.067 0.0563 0.047 0.04 0.02 0 0.026 0.02 0.004 US US US Saudi Ar Jpn Fin EU 0.04%40.0023% n180030571000 10000n1/10 Partinen M, Hublin C: Epidemiology of Sleep

More information

Various function and toxicity of iron Key words 1) Hentze, M. W. et al: Cell, 117, 285-297 (2004) 2) Ganz, T.: Blood, 102, 783-788 (2003) 3) Nemeth, E. et al.: Science, 306, 2090-2093 (2004) 4) Hentze,

More information

インターネット概論 第07回(2004/11/12) 「SFC-CNSの現状」

インターネット概論 第07回(2004/11/12) 「SFC-CNSの現状」 / / / : AES 128bit) 196bit 256bit 128bit) 10 12 14 196bit) 12 12 14 256bit) 14 14 14 (n, e) (n, d) M M : 2 ( 101 5) [e ] [e ] n = p * q (p q ) (n) = (p-1)(q-1) gcd( (n), e) = 1; 1 < e < (n) d = e^-1

More information

Evaluation of exercise tolerance and cardiac function on symptom limited tredmill exercise test in chronic hemodialysis patients, and exercise trainin

Evaluation of exercise tolerance and cardiac function on symptom limited tredmill exercise test in chronic hemodialysis patients, and exercise trainin Evaluation of exercise tolerance and cardiac function on symptom limited tredmill exercise test in chronic hemodialysis patients, and exercise training HIROKI BASE, RYOICHI NAKAMURA 3rd Department of Internal

More information

et al No To Shinkei Clin Neurol Neurology et al J Neurosurg et al Arch Neurol et al Angiology

et al No To Shinkei Clin Neurol Neurology et al J Neurosurg et al Arch Neurol et al Angiology 37 Recommendations for the Management of Moyamoya Disease A Statement from Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) Research on intractable diseases of the

More information

Synagis RS RSRespiratory Syncytial Virus RSBPD CHDRS RS RS BPD CHD 50mg100mg RS20138 RS Respiratory Syncytial Virus RS

Synagis RS RSRespiratory Syncytial Virus RSBPD CHDRS RS RS BPD CHD 50mg100mg RS20138 RS Respiratory Syncytial Virus RS RS Synagis RS RSRespiratory Syncytial Virus RSBPD CHDRS RS RS1998 7020021BPD 200510CHD 50mg100mg2012 812 RS20138 RS Respiratory Syncytial Virus RS 28 12 29 35 6 6BPD24 24CHD 24 24 28 2935 RS 12 6 RS BPD

More information

The Heart Healthy Tocotrienol Complex Tocomin SupraBio

The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio 1. Fact Sheet No. 317; World Health Organization (WHO), 2007 2. LLOYD-JONES D. et al. Circulation

More information

untitled

untitled 85 86 87 Medical Group AISEIKAI 88 89 Medical Group AISEIKAI 90 91 92 93 94 95 96 97 98 99 100 101 102 103 Medical Group AISEIKAI 104 105 106 107 108 Eur J Radiol. J Comput Assist Tomogr Circ J JACC Cardiovasc

More information

AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urol

AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urol AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urology, Kumamoto University College of Medicine (Director:

More information

Online publication August 10, 症例報告 要旨 : S3 S10 S CT S3 S S3 S10 J Jpn Coll Angiol 2013; 53:

Online publication August 10, 症例報告 要旨 : S3 S10 S CT S3 S S3 S10 J Jpn Coll Angiol 2013; 53: Online publication August 10, 2013 121 症例報告 1 1 2 1 1 3 1 1 1 1 1 1 要旨 : 42 1994 S3 S10 S10 2010 9 CT S3 S10 2011 9 S3 S10 J Jpn Coll Angiol 2013; 53: 121 125 Key words: pulmonary arteriovenous malformation,

More information

薬物治療学分野症例シリーズ7

薬物治療学分野症例シリーズ7 ( 4 ) 1-2 1-2 (New Engl J Med, 2004) I, II III () IV NCI-CTC CTC Version 2.0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ( ( 21 22 23 CTC Version 2.0 24 瘙 Non-steroidal anti-inflammatory

More information

C11В4_06.p65

C11В4_06.p65 1300030506010608 0508010806-0303060304090704010508020102 070106000304050606030608 0503040608 11 0003020600060108 000403070508 4 02030808090405 2006 01ィ ィョ ツィェ06-ィー02060802ィーィィ ツ0209ィコィィィヲ 03ィョ08ィェィ 05

More information

公文書vol.6.06.indd

公文書vol.6.06.indd Vol.6 201668 June, July and ugust 2016 NTIONL RCHIVES OF JPN NEWS Special 3 1 2? 6 Special 2014 2 3 NTIONL RCHIVES OF JPN NEWS Vol.6 Special 2 3! 2 p.8! 6 28 4 1 3 9 rchivist Interview 2 4 13? 5 NTIONL

More information

HP-GLユーザーズガイド

HP-GLユーザーズガイド JPN i ii iii iv v vi vii viii 1 1 1-1 1 1-2 1 1-3 1 1-4 2 2 2-1 2 2-2 2 2-3 2 2-4 2 2-5 2 2-6 2 2-7 2 2-8 2 2-9 2 2-10 2 2-11 2 2-12 2 2-13 2 2-14 2 2-15 2 2-16 2 2-17 2 2-18 2 2-19 2 2-20 2 2-21 2 2-22

More information

要望番号 ;Ⅱ 未承認薬 適応外薬の要望 ( 別添様式 1) 1. 要望内容に関連する事項 要望 者 ( 該当するものにチェックする ) 優先順位 学会 ( 学会名 ; 日本ペインクリニック学会 ) 患者団体 ( 患者団体名 ; ) 個人 ( 氏名 ; ) 2 位 ( 全 4 要望中 )

要望番号 ;Ⅱ 未承認薬 適応外薬の要望 ( 別添様式 1) 1. 要望内容に関連する事項 要望 者 ( 該当するものにチェックする ) 優先順位 学会 ( 学会名 ; 日本ペインクリニック学会 ) 患者団体 ( 患者団体名 ; ) 個人 ( 氏名 ; ) 2 位 ( 全 4 要望中 ) 未承認薬 適応外薬の要望 ( 別添様式 1) 1. 要望内容に関連する事項 要望 者 ( 該当するものにチェックする ) 優先順位 学会 ( 学会名 ; 日本ペインクリニック学会 ) 患者団体 ( 患者団体名 ; ) 個人 ( 氏名 ; ) 2 位 ( 全 4 要望中 ) 成分名 ( 一般名 ) 塩酸リドカイン 販売名 0.5%/1%/2% キシロカイン 要望する医薬品要望内容 会社名 国内関連学会

More information

日本皮膚科学会雑誌第122巻第2号

日本皮膚科学会雑誌第122巻第2号 J Dermatol Sci Vitam Horm NEnglJMed Lancet J Clin Invest Antitoxid Redox Signal Diabetes Metab Res Rev Diabetes Care Diabet Med Diabetes care Diabetes Care J Foot Ankle Surg Wound Repair Regen Lancet Foot

More information

寄稿論文 高い発ガン活性を示す鉄キレートお構造特性 | 東京化成工業

寄稿論文 高い発ガン活性を示す鉄キレートお構造特性 | 東京化成工業 NTBI = nontransferrin-bound iron NTBI DNA H DNA 2 NTBI NTBI NTBI NTBI NTBI NTBI (nta) (nta) (nta) NTBI (nta) (nta) NTBI (nta)ntbi Fe-(nta) (nta) N(CH 2 CH) 3 HCCH 2 NHCH 2 CH 2 NHCH 2 CH (HCCH 2 ) 2 NH

More information

ネットワークガイド/本編

ネットワークガイド/本編 JPN ii iii iv v 9 vi vii 1 CHAPTER 1-1 1-2 1-3 1-4 1-5 1-6 1-7 2 CHAPTER 2-1 2-2 1 2 3 2-3 4 5 2-4 6 a b a b 7 2-5 8 9 2-6 10 a b a b 2-7 11 a b b a 2-8 a b a a b b a b 2-9 a b a b 12 2-10 a b a b 2-11

More information

ESC/Pユーザーズガイド

ESC/Pユーザーズガイド JPN i ii iii iv v vi vii viii 1 1 1-1 1 1-2 1 1-3 1 1-4 2 2-1 2 e? e? h? h? h? h? h? h? e??ee??ee? e??ee??ee???????????ee??ee???ee??ee? g g g g g g 2 2 2-2 2 2-3 2-4 2 2 2-5 2 2-6 2 2-7 2 2-8 2 2-9 2 2-10

More information

Low Friction Anatomic 1

Low Friction Anatomic 1 Ver.6.2 LFA Total Knee System Low Friction Anatomic 1 Low Friction Advanced Ceramic Technology Anatomic Modular System 2 3 0.1 0-0.1-0.2-0.3-0.4 0 50 100 150 200 4 5 6 A3 A5 A4 A2 A1 Anterior Med. Lat.

More information

65-6 小泉・谷所・野村・楠本.pwd

65-6 小泉・谷所・野村・楠本.pwd CSA p r p r 5N 20N 5N 10N 15N 20N Komiya et al 0kgf 25 kgf MRI 50M 171.1 5.15 cm, 64.3 7.78 kg, 26.13 1.420 cm Oldfield The Edinburgh Inventory LEFT RIGHT RIGHT RIGHT LEFT LEFT RIGHT Oldfield Laterality

More information

Table 1 Muscle weight (g) and those ratio (%) in M. quadriceps femoris Table 2 Cross-sectional area (mm2) and those ratio (%) in M, quadriceps femoris

Table 1 Muscle weight (g) and those ratio (%) in M. quadriceps femoris Table 2 Cross-sectional area (mm2) and those ratio (%) in M, quadriceps femoris Table 1 Muscle weight (g) and those ratio (%) in M. quadriceps femoris Table 2 Cross-sectional area (mm2) and those ratio (%) in M, quadriceps femoris Fig. 1 Comparison of cross-sectional area in human

More information

本文.indd

本文.indd CQ ACC/AHA PECO PatientExposure Comparison OutcomePECO low-density lipoprotein cholesterol LDL C cholesterol cholesterol intensive OR agressive CQ target LDL C PubMed Systematic Reviews Clinical Study

More information

LBP-1810 LIPS機能ガイド

LBP-1810 LIPS機能ガイド レーザビームプリンタ LIPS機能ガイド ご使用前に必ずこの取扱説明書をお読みください 将来いつでも使用できるように大切に保管してください JPN JPN JPN JPN JPN Copyright 2001 Canon Inc. ALL RIGHTS RESERVED II III IV V VI VII VIII IX X 1 2 3 4 HDD 2 5 6 7 8 9 10 11 12 1

More information

膵癌超音波診(案)

膵癌超音波診(案) 1 2 3 4 5 6 7 8 9 10 2009 7 6 2 a. invasive ductal carcinoma * 1 b. endocrine neoplasm c. Solid pseudopapillary neoplasm d. tumor producing pancreatitis * 2 * 1 invasive ductal carcinomas papillary adenocarcinoma

More information

3) Albright, Baid, Cope, Bloomberg: Am. Jour. Med. Scond 187, 1934. 4) Albright, Sulkowitch, Bloomberg: Arch. Int. Med. 62, 1938. 5) Allegri: Zit. mach Biedle. 6) Anderson: Arch. of Path. 27, 1939. 7)

More information

2011 Vol.53 No.3 Jpn J School Health Jpn J School Health Jpn J School Health Kagawa Nutrition University Jpn J School Health Kagawa Nutrition University Jpn J School Health Jpn J School Health Japan

More information

*Criteria 1) B-marker positive 2) Variability in nuclear size and shape 3) Giant cells and multinucleated cells

*Criteria 1) B-marker positive 2) Variability in nuclear size and shape 3) Giant cells and multinucleated cells *Criteria 1) B-marker positive 2) Variability in nuclear size and shape 3) Giant cells and multinucleated cells Abbreviation: LC=large cleaved nuclei, LNC=large non-cleaved nuclei, IMBL=immunoblastic nuclei,

More information

a) DifcoTM Brain Heart Infusion agar, DifcoTM Brain Heart Infusion, Becton, Dickinson and Company, U.S.A.

a) DifcoTM Brain Heart Infusion agar, DifcoTM Brain Heart Infusion, Becton, Dickinson and Company, U.S.A. a) DifcoTM Brain Heart Infusion agar, DifcoTM Brain Heart Infusion, Becton, Dickinson and Company, U.S.A. [1] Buttenschon J, Svensmark B, Kyrval J: Zentralb Veterinarmedizin A, 42, 633-641 (1995) [2]

More information

I5577ユーザーズガイド

I5577ユーザーズガイド JPN i ii iii iv v vi vii viii ix x 1 1 1-1 1 1-2 1 1-3 1 1-4 1 1-5 1 1-6 2 2-1 e? e? h? h? h? h? h? h? e??ee??ee??ee? e??ee??ee??ee???????????ee??ee??ee???ee??ee??ee? g g g g g g 2 2 2 2-2 2 2-3 2 2-4

More information

卵 巣 出 血 を 伴 え る メ ツケ ル 憩 室 の 一 例 と 自験 例 四 例 を 含 め て 本 邦 に於 け る メ ツ ケ ル 憩 室 の 統 計 的観 察 福 岡市 香椎 外科 清 成 (本論 文の 要 旨は 第25回 正 智 日本臨 床 外科 医 学 会 総 会 に て発 表 す) 術 後 経 過 良 好 に し て10日 緒 言 日に全 治 退 院す 組 織 学 的 に 胃 底

More information

864 薬 師 寺 猛,河 B.副 1) 野 作 重 治 用 局 所 刺戟 作 用 局所 刺 戟作 用 は,そ の判 定 を正 確 にす るた め次 の2種 の方 法 を行 つ た. 先 ず家 兎 の眼 に2%E-17-2及 び2%Lidocaineを 点 眼 し,家 兎 結 膜及 び角 膜 ρ 充血 或 い は1角 膜上皮の 剥 離の 有無 を検 し たが,両 者 の いず れ に もか ゝる局

More information

11.b a. b. 100% d. e. 12. b, e a. b. LET LET 30cGy/h(0.5cGy/min) G2 G2 () d. 1cGy/ 100cGy/ e.

11.b a. b. 100% d. e. 12. b, e a. b. LET LET 30cGy/h(0.5cGy/min) G2 G2 () d. 1cGy/ 100cGy/ e. 1. 3.7GBq 1.3mSv 1/10 d 1 5 11.b a. b. 100% d. e. 12. b, e a. b. LET LET 30cGy/h(0.5cGy/min) G2 G2 () d. 1cGy/ 100cGy/ e. 13. a, c a. b. LET / d. LQ e. LQ 14. d, e a. b. d. e. 15. a NIPPON ACTA RADIOLOGICA

More information

CW3_A6075D02.indd

CW3_A6075D02.indd 1/7 Japanese Journal of Comprehensive Rehabilitation Science (2011) Original Article Miyasaka H, Kondo I, Kato H, Takahashi C, Uematsu H, Yasui C, Tani A, Miyata M, Wada N, Teranishi T, Wada Y, Sonoda

More information

長崎Edwards

長崎Edwards BMJ 1997; 315: 909-15 Esophageal Doppler FTc > 0.35 Protocol (1997) Esophageal Doppler GDT Anesthesiology 2002; 97: 820-6 Major surgery Esophageal Doppler FTc >0.35 GDT PONV LOSGDT5 vs 7 6% hetastarchgoal

More information

CHEMOTHERAPY FEB Table 1 Background of volunteers

CHEMOTHERAPY FEB Table 1 Background of volunteers CHEMOTHERAPY FEB. 1985 Table 1 Background of volunteers Table 3 Reproducibility of saisomicln In the EIA and the RIA Fig.1 Comparison of the EIA with the RIA or bioassay of sisomicin Table 4 Blood levels

More information

Complex sleep apnea syndrome and sleep disordered breathing in patients with cardiovascular disease V o l. 4 1 N o. 3 ( 2 0 0 9 ) V o l. 4 1 N o. 3 ( 2 0 0 9 ) V o l. 4 1 N o. 3 ( 2 0 0 9 ) Sleep J Clin

More information

理学療法科学シリーズ臨床運動学第6版サンプル

理学療法科学シリーズ臨床運動学第6版サンプル μ μ μ μ μ α μ 1) Appell HJ: Skeletal muscle atrophy during immobilization. Int J Sports Med 7: 1-5, 1986. 2) Bohannon RW: Make tests and break tests of elbow flexor muscle strength.

More information

untitled

untitled 2003 300 2015 500 2015 2006 quality of lifeqol 2012 2016 5 research guideline training practice 4 QOL QOL 2013 3 7 1 8 2 8 1 22 23 2 3 3 47 1 2 3 4. 49 1 50 2 51 1 2 3 4 3 73 1 2 3 4 5 87 1 88 2 88 1 2

More information

109

109 108 1 2 3 109 110 111 112 1 c c < c c< B N a d 1 2 3 5 8 9 0 ; 2c< rc a h 3c 113 1p 2c< 3c< a r 4cc 1p 2 c 3c< c p a c 4p 5 c rr c c Cr m e 114 1 c c < c< B N d a 1 3 5 9 0 ; 2c< B ; p c< BN50; ar h 3c

More information

Studies on handgrip test; H. Effect of aging on cardiovascular responses. Tan Watanabe*, Long-Tai Fu*, Chihoko Togo*, Kazuzo Kato* and Shintaro Koyama

Studies on handgrip test; H. Effect of aging on cardiovascular responses. Tan Watanabe*, Long-Tai Fu*, Chihoko Togo*, Kazuzo Kato* and Shintaro Koyama Studies on handgrip test; H. Effect of aging on cardiovascular responses. Tan Watanabe*, Long-Tai Fu*, Chihoko Togo*, Kazuzo Kato* and Shintaro Koyama*. The Cardiovascular Insttiute. Key words Heart Cardiac

More information

Blood & Vessel : 515

Blood & Vessel : 515 Key words: platelet adhesiveness, platelet retention, glass bead column. *Platelet retention test with Hellem II glass bead columns. of Hematologic Research, Toranomon General Hospital, Okinaka Memorial

More information

5) K. Irukayama, T. Kondo, F. Kai, M. Fujiki, Kuma. moto Med. J., 14, 157(1961). 6) K. Irukayama, M. Fujiki, F. Kai, T. Kondo, ibid., 15, 1(1962). 7)

5) K. Irukayama, T. Kondo, F. Kai, M. Fujiki, Kuma. moto Med. J., 14, 157(1961). 6) K. Irukayama, M. Fujiki, F. Kai, T. Kondo, ibid., 15, 1(1962). 7) 5) K. Irukayama, T. Kondo, F. Kai, M. Fujiki, Kuma. moto Med. J., 14, 157(1961). 6) K. Irukayama, M. Fujiki, F. Kai, T. Kondo, ibid., 15, 1(1962). 7) K. Irukayama, F. Kai, M. Fujiki, T. Kondo, ibid., 15,

More information

I lay my all at people feet.PDF

I lay my all at people feet.PDF it will be provided god ehzhove ear flower (seed) 174 list heart rice plant ear chaff yhwh truth islander all whwhjhwh 4654 2 whwhjhwh truth ehzhove ehzhove 3000 2 7 1186 608 1017 1291 6000 6000 6000

More information

1) Karpatkin, S.: Blood, 51: 307, 1978. 2) Karpatkin, S.: Ann. Intern. Med., 89: 200, 1978. 3) Brecker, C. and Cronkite, E. P.: J. Appl. Phy siol., 3: 365, 1950. 4) Mielke, C. H., Jr., et al.: Blood, 34:

More information

超音波40-5廣岡先生(膵癌)_念*.indd

超音波40-5廣岡先生(膵癌)_念*.indd 1 2 3, 4, 5, 6, 7, 8, 9, 10 11,.2009 7 6,, 2.,,.,.,,,.,,,.,,,,.,,.,. a. invasive ductal carcinoma * 1 b. neuroendocrine neoplasm c. Solid-pseudopapillary neoplasm d. mass-forming tumor-producing pancreatitis

More information

Key words: three-dimensional bite force, value of bite force, direction of bite force, maxillary clutch, mandibular clutch

Key words: three-dimensional bite force, value of bite force, direction of bite force, maxillary clutch, mandibular clutch J Jpn Prosthodont Soc, 35: 366 `380, 1991. The Influence of Craniofacial Form on Bite Force and EMG Activity of the Masticatory MusclesII. The Three-dimensional Bite Force Measurement Sytem Toshimitsu

More information

THE SIMPLIFIED EVALUATION OF POST-EXERCISE VAGAL REACTIVATION AND APPLICATION IN ATHLETIC CONDITIONING JUN SUGAWARA, YUTAKA HAMADA, YOSHIHARU NABEKURA, TAKAHIKO NISHIJIMA and MITSUO MATSUDA It has been

More information

Key words : ataxia, sensory disturbance, lacunar infarction, pontine infarction, MRI

Key words : ataxia, sensory disturbance, lacunar infarction, pontine infarction, MRI Key words : ataxia, sensory disturbance, lacunar infarction, pontine infarction, MRI 病 巣 と反 対側 に小 脳 症 状 と感 覚 障害 を 呈 した橋 梗 塞 の 1 例 図 1 a :頭 部MRI水 平 断 T1WI (TR 平 断 T2WI 600, め る.b: 頭 部MRI水 TE80). 梗 塞 巣 は橋

More information

Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Labor

Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Labor Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Laboratory Medicine University School of Medicine, Tohoku

More information

日本皮膚科学会雑誌第121巻第14号

日本皮膚科学会雑誌第121巻第14号 World J Surg Burns Burns JTrauma Lancet Lancet Surg Gynecol Obste J Burn Care Rehabil BMJ Pediatr Emerg Care The Treatment of Burns Burns, A Team Approach Surg Gynecol Obstet NEnglJMed J Burn Care Rehabil

More information

CSRレポート2010(一括版)

CSRレポート2010(一括版) CS R Corporate Social Responsibility Report 2010 1 Message 2 SG HOLDINGS GROUP Corporate Social Responsibility Report 2010 3 Message 4 SG HOLDINGS GROUP Corporate Social Responsibility Report 2010 1 2

More information

Post-Traumatic Osteolysis of the Distal End A Case of Post-Traumatic Osteolysis of the Distal End of the Clavicle by G. Kinoshita, M. Maeda, H.Takaiwa

Post-Traumatic Osteolysis of the Distal End A Case of Post-Traumatic Osteolysis of the Distal End of the Clavicle by G. Kinoshita, M. Maeda, H.Takaiwa Post-Traumatic Osteolysis of the Distal End A Case of Post-Traumatic Osteolysis of the Distal End of the Clavicle by G. Kinoshita, M. Maeda, H.Takaiwa and K. Nakano Department of Orthopaedic Surgery, Hyogo

More information

46-2-最終版.pdf

46-2-最終版.pdf Jpn. J. Health Phys., 46 (2) 140 147 (2011) * 1 * 2 * 2 * 2 2010 10 22 2011 2 21 Development and Operational Results of a Real-time Remote Biological Information Monitoring Device for the Workers Wearing

More information

レーザビームプリンタ Satera ユーザーズガイド

レーザビームプリンタ Satera ユーザーズガイド JPN CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM ii iii iv v vi vii viii ix x xi xii a b c d b c d a xiii xiv xv xvi xvii xviii xix xx 1 CHAPTER 1-1 1-2 1-3 1-4 b a n m l k j c d f g e i h a b c d

More information

1) linisely, M. H. : Postburn Pathologic circulatory Physiology. F. A. Davis Co. philadelphia 1962, 2) James, G. W. et. al. : The anemia of thermal injury : Erythropoiesis and hemoglobin metabolism studied

More information

2003 9 9 13 30 17 00

2003 9 9 13 30 17 00 2003 12 2003 9 9 13 30 17 00 youkoinoue@cc.nara-wu.ac.jp 50 1954 tetsukubota@hotmail.com 1973 hshimizu@jikei.ac.jp 1941 mtanaka@fmu.ac.jp 1936 hirate@arch.t.u-tokyo.ac.jp 1954 masao@sic.shibaura-it.ac.jp

More information

JJRM5005/04.短報.責了.indd

JJRM5005/04.短報.責了.indd Jpn J Rehabil Med 2013 ; : 319.327 1 2 3 4 5 6 Survey of the Electronic Medical Recoding System Used in Kaifukuki Rehabilitation Wards Hidekazu SUGAWARA, 1 Tetsutaro YAHATA, 2 Hideto OKAZAKI, 3 Mitsuhiro

More information